Literature DB >> 23051047

Putting vital stains in context.

Nathan Efron1.   

Abstract

While vital staining remains a cornerstone in the diagnosis of ocular disease and contact lens complications, there are many misconceptions regarding the properties of commonly used dyes by eye-care practitioners and what is and what is not corneal staining after instillation of sodium fluorescein. Similarly, the proper use and diagnostic utility of rose Bengal and lissamine green B, the other two ophthalmic dyes commonly used for assessing ocular complications, have similarly remained unclear. Due to the limitations of vital stains for definitive diagnosis, concomitant signs and symptoms in addition to a complete patient history are required. Over the past decade, there have been many reports of a type of corneal staining--often referred to as solution-induced corneal staining (SICS)--that is observed with the use of multipurpose solutions in combination with soft lenses, more specifically silicone hydrogel lenses. Some authors believe that SICS is a sign of lens/solution incompatibility; however, new research shows that SICS may be neither a measure of lens/solution biocompatibility nor 'true' corneal staining, as that observed in pathological situations. A large component of SICS may be a benign phenomenon, known as preservative-associated transient hyperfluorescence (PATH). There is a lack of correlated signs and/or symptoms with SICS/PATH. Several properties of SICS/PATH, such as appearance and duration, differentiate it from pathological corneal staining. This paper reviews the properties of vital stains, their use and limitations in assessment of the ocular surface, the aetiology of corneal staining, characteristics of SICS/PATH that differentiate it from pathological corneal staining and what the SICS/PATH phenomenon means for contact lens-wearing patients.
© 2012 The Author. Clinical and Experimental Optometry © 2012 Optometrists Association Australia.

Entities:  

Keywords:  cornea; fluorescein; preservative-associated transient hyperfluorescence; solution-induced corneal staining; vital stains

Mesh:

Substances:

Year:  2012        PMID: 23051047     DOI: 10.1111/j.1444-0938.2012.00802.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  5 in total

1.  Dynamics of Fluorescent Imaging for Rapid Tear Thinning.

Authors:  L Zhong; R J Braun; C G Begley; P E King-Smith
Journal:  Bull Math Biol       Date:  2018-10-15       Impact factor: 1.758

2.  A novel scale for describing corneal staining.

Authors:  Jill Woods; Jalaiah Varikooty; Desmond Fonn; Lyndon W Jones
Journal:  Clin Ophthalmol       Date:  2018-11-19

3.  A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease.

Authors:  Mike Taylor; George Ousler; Gail Torkildsen; Claire Walshe; Matthew C T Fyfe; Adele Rowley; Steve Webber; John D Sheppard; Ajay Duggal
Journal:  Clin Ophthalmol       Date:  2019-02-12

4.  The use of preservatives in dry eye drops.

Authors:  Karen Walsh; Lyndon Jones
Journal:  Clin Ophthalmol       Date:  2019-08-01

Review 5.  Regenerative Approaches and Future Trends for the Treatment of Corneal Burn Injuries.

Authors:  Gabriele Saccu; Valeria Menchise; Cristina Giordano; Daniela Delli Castelli; Walter Dastrù; Rinaldo Pellicano; Emanuela Tolosano; Phuc Van Pham; Fiorella Altruda; Sharmila Fagoonee
Journal:  J Clin Med       Date:  2021-01-16       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.